
First-in-class therapies designed to reprogram the immune system
ABOUT COUR
We are a group of dedicated scientific, medical, and business professionals who are driven to find treatments and cures of immune-mediated diseases. By focusing our research on the root cause of disease we seek to provide treatments previously unavailable to doctors and their patients.
COUR Nanoparticle Platform: CNP

- Reprograms the immune system
- Induces tolerance to specific antigens
- Preserves all immune functionality
Inducing immune tolerance in autoimmune and allergic diseases:
Rare Disease
- Myasthenia Gravis
- Pemphigus Vulgaris
COUR is rapidly advancing its pipeline of first-in-class therapies for immune-mediated diseases
